XML 56 R6.htm IDEA: XBRL DOCUMENT v2.4.0.8
CONSOLIDATED STATEMENTS OF STOCKHOLDERS EQUITY (USD $)
Series B Preferred Stock
Common Stock
Additional Paid-In Capital
Accumulated Deficit
Accumulated Other Comprehensive Income / Loss
Total
Beginning Balance - Amount at Dec. 31, 2011 $ 3,115 $ 130,747 $ 45,432,447 $ (65,526,029) $ (2,243,362) $ (22,203,082)
Beginning Balance - Shares at Dec. 31, 2011 3,115,225 130,746,890        
Stock-based compensation & options exercised, Shares   321,965        
Stock-based compensation & options exercised, Amount   322 258,271       258,593
Shares issued to consultants and other services, Shares   1,000,000        
Shares issued to consultants and other services, Amount   1,000 426,466       427,466
Shares issued to secured lender, Shares   17,699,172        
Shares issued to secured lender, Amount   17,699 10,848,280       10,865,979
Issuance and exercise of warrants, Shares   1,432,667        
Issuance and exercise of warrants, Amount   1,433 1,018,167       1,019,600
Conversion of related party note, Shares   9,062,900        
Conversion of related party note, Amount   9,063 4,098,078       4,107,141
Beneficial conversion feature on related party note      884,851       884,851
Conversion of Series B preferred to common stock, Shares   17,500        
Conversion of Series B preferred to common stock, Amount   17            
Cilion, Inc. merger, Shares   20,000,000        
Cilion, Inc. merger, Amount   20,000 12,491,200       12,511,200
Other comprehensive loss         (74,531) (74,531)
Net loss       (4,282,265)    (4,282,265)
Ending Balance, Amount at Dec. 31, 2012 3,098 180,281 75,457,760 (69,808,294) (2,317,893) 3,514,952
Ending Balance, Shares at Dec. 31, 2012 3,097,725 180,281,094        
Stock-based compensation & options exercised, Shares   264,005        
Stock-based compensation & options exercised, Amount   264 1,158,940       1,159,204
Shares issued to consultants and other services, Shares   1,767,715        
Shares issued to consultants and other services, Amount   1,768 599,100       600,868
Shares issued to secured lender, Shares   9,872,201        
Shares issued to secured lender, Amount   9,872 3,606,412       3,616,284
Issuance and exercise of warrants, Shares   2,638,636        
Issuance and exercise of warrants, Amount   2,639 1,477,410       1,480,049
Conversion of related party note, Shares   1,826,547        
Conversion of related party note, Amount   1,826 820,120       821,946
Conversion of Series B preferred to common stock, Shares   696,664        
Conversion of Series B preferred to common stock, Amount   697            
Issuance of common stock through equity offering, Shares   2,390,000        
Issuance of common stock through equity offering, Amount   2,390 1,072,810       1,075,200
Other comprehensive loss         (598,443) (598,443)
Net loss       (24,437,209)    (24,437,209)
Ending Balance, Amount at Dec. 31, 2013 $ 2,401 $ 199,737 $ 84,192,552 $ (94,245,503) $ (2,916,336) $ (12,767,149)
Ending Balance, Shares at Dec. 31, 2013 2,401,061 199,736,862